News Detail
Chandigarh, 23 March 2025: PGI's medical innovation, conceived and developed entirely in India, is set to redefine neuropathic pain management, providing a lifeline to millions suffering from conditions like diabetic neuropathy and sciatica. The revolutionary Quantitative Sensory......
View Details
Source :
Quantitative Sensory Testing
PGI medical innovation
neuropathic pain diagnosis
AI-driven device
affordable healthcare solutions
Related News
- A drug manufacturing facility operating without license busted in Kharkhoda (25-03-2025)
- Delhi HC allows Natco to make Roche's spinal muscular atrophy drug 'Risdiplam' in public interest (25-03-2025)
- Enforce regulations, strengthen penalties to fight the menace of counterfeit drugs: Parliamentary Panel (25-03-2025)
- Supplement firm Bioventra warns of online fakes (25-03-2025)
- FDA drug approvals drops, but smaller pharma leads innovation: GlobalData (25-03-2025)
- No staff involved in promoting fake drugs, vaccination: Odisha Health Minister (25-03-2025)
- Centre to introduce standardised hospital billing format to ensure transparency (24-03-2025)
- CDSCO asks MSME pharma firms to apply online for Schedule M extension (24-03-2025)
- Father and son arrested for unlicensed medicine sales, concealed drugs in cowshed (24-03-2025)
- Chhattisgarh EOW Arrests Five Officers in ₹660 Cr Procurement Scam (24-03-2025)